Erste Asset Management Gmb H Viatris Inc Transaction History

Erste Asset Management Gmb H

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $0 - $0	0 New	0 $0
Q2 2024 Nov 26, 2024	BUY	$10.05 - $12.02 $0 - $0	0 New	0 $0
Q1 2024 Nov 26, 2024	SELL	$11.27 - $13.53 $552 - $662	-49 Closed	0 $0
Q3 2023 Nov 26, 2024	BUY	$9.59 - $11.35 $469 - $556	49 New	49 $491,000
Q2 2023 Nov 26, 2024	BUY	$9.02 - $10.29 $441 - $504	49 New	49 $485,000
Q1 2023 Nov 26, 2024	BUY	$9.2 - $12.26 $0 - $0	0 New	0 $0
Q4 2022 Nov 26, 2024	BUY	$8.72 - $11.56 $0 - $0	0 New	0 $0
Q3 2022 Nov 26, 2024	BUY	$8.48 - $11.13 $0 - $0	0 New	0 $0
Q2 2022 Nov 26, 2024	BUY	$9.95 - $12.27 $0 - $0	0 New	0 $0
Q1 2022 Nov 22, 2024	BUY	$9.81 - $15.4 $0 - $0	0 New	0 $0
Q4 2021 Nov 22, 2024	BUY	$12.09 - $14.68 $0 - $0	0 New	0 $0
Q3 2021 Nov 22, 2024	SELL	$13.25 - $15.13 $2,742 - $3,131	-207 Closed	0 $0
Q2 2021 Nov 22, 2024	SELL	$12.97 - $16.15 $11,517 - $14,341	-888 Reduced 81.1%	207 $2.96 Million
Q4 2020 Nov 22, 2024	BUY	$14.3 - $18.74 $15,658 - $20,520	1,095 New	1,095 $19.5 Million

1,136

989M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.18B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.